These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7947604)
1. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin. Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604 [TBL] [Abstract][Full Text] [Related]
2. Thrombospondin peptides inhibit the secretion-dependent phase of platelet aggregation. Rabhi-Sabile S; Thibert V; Legrand C Blood Coagul Fibrinolysis; 1996 Mar; 7(2):237-40. PubMed ID: 8735828 [TBL] [Abstract][Full Text] [Related]
3. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation. Legrand C; Thibert V; Dubernard V; Bégault B; Lawler J Blood; 1992 Apr; 79(8):1995-2003. PubMed ID: 1562725 [TBL] [Abstract][Full Text] [Related]
4. A recombinant NH(2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Ferrari do Outeiro-Bernstein MA; Nunes SS; Andrade AC; Alves TR; Legrand C; Morandi V Matrix Biol; 2002 Jun; 21(4):311-24. PubMed ID: 12128069 [TBL] [Abstract][Full Text] [Related]
5. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor. Bonnefoy A; Hantgan R; Legrand C; Frojmovic MM J Biol Chem; 2001 Feb; 276(8):5605-12. PubMed ID: 11094060 [TBL] [Abstract][Full Text] [Related]
6. Role of thrombospondin in platelet aggregation. Leung LL J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568 [TBL] [Abstract][Full Text] [Related]
7. Proteolysis of thrombospondin during cathepsin-G-induced platelet aggregation: functional role of the 165-kDa carboxy-terminal fragment. Rabhi-Sabile S; Pidard D; Lawler J; Renesto P; Chignard M; Legrand C FEBS Lett; 1996 May; 386(1):82-6. PubMed ID: 8635609 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel monoclonal antibody (V58A4) raised against a recombinant NH2-terminal heparin-binding fragment of human endothelial cell thrombospondin. Morandi V; Edelman L; Legrand YJ; Legrand C FEBS Lett; 1994 Jun; 346(2-3):156-60. PubMed ID: 8013625 [TBL] [Abstract][Full Text] [Related]
9. Thrombospondin as an agglutinin of platelets. Satoh S; Takahashi K; Sakuragawa N Thromb Res; 1993 Dec; 72(6):509-17. PubMed ID: 8128455 [TBL] [Abstract][Full Text] [Related]
10. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754 [TBL] [Abstract][Full Text] [Related]
11. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367 [TBL] [Abstract][Full Text] [Related]
13. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Boukerche H; McGregor JL Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471 [TBL] [Abstract][Full Text] [Related]
14. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction. Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697 [TBL] [Abstract][Full Text] [Related]
15. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain. Yabkowitz R; Lowe JB; Dixit VM J Biol Chem; 1989 Jun; 264(18):10888-96. PubMed ID: 2659597 [TBL] [Abstract][Full Text] [Related]
16. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins. Tuszynski GP; Rothman VL; Deutch AH; Hamilton BK; Eyal J J Cell Biol; 1992 Jan; 116(1):209-17. PubMed ID: 1730745 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
18. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1. Voland C; Serre CM; Delmas P; Clézardin P J Bone Miner Res; 2000 Feb; 15(2):361-8. PubMed ID: 10703939 [TBL] [Abstract][Full Text] [Related]
19. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin. Kao KJ; Shaut DM; Klein PA Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001 [TBL] [Abstract][Full Text] [Related]
20. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood. Maugeri N; Di Fabio G; Barbanti M; de Gaetano G; Donati MB; Cerletti C Thromb Haemost; 2007 Jun; 97(6):965-73. PubMed ID: 17549299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]